Releasing agent: Difference between revisions

>Josikins
m Text replacement - " | https://www.ncbi." to " (PubMed.gov / NCBI) | https://www.ncbi."
>Kaylee
No edit summary
Line 1: Line 1:
A '''releasing agent''', or simply releaser, is a drug that induces the release of a [[neurotransmitter]] from the presynaptic [[neurone]] into the synapse, leading to a rise in the extracellular concentrations of the neurotransmitter, therefore resulting in increased neurotransmission.  Many drugs use neurotransmitter release to exert their psychological and physiological effects, namely the [[amphetamines]] and related compounds. Virtually all currently known releasing agents affect the monoamine neurotransmitters [[serotonin]], [[noradrenaline]], and/or [[dopamine]], and as such, they are often referred to more formally as monoamine releasing agents (MRAs). MRAs may be selective for a particular neurotransmitter or non-selective and affect multiple neurotransmitters.
A '''releasing agent''' is a drug that induces the release of a [[neurotransmitter]] from the presynaptic [[neurone]] into the synapse, leading to elevated extracellular concentrations of the neurotransmitter, therefore resulting increased neurotransmission.  Many drugs use neurotransmitter release to exert their psychological and physiological effects, namely the [[amphetamines]] and related compounds. Virtually all currently known releasing agents affect the monoamine neurotransmitters [[serotonin]], [[noradrenaline]], and/or [[dopamine]], and as such, they are often referred to more formally as monoamine releasing agents (MRAs). MRAs, like [[agonists]] may be selective for a particular neurotransmitter or non-selective and affect multiple neurotransmitters.


==Mechanism of Action==
==Mechanism of Action==